Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1983 1
1985 1
1986 1
1990 2
1991 3
1993 3
1994 7
1995 5
1996 7
1997 8
1998 3
1999 11
2000 11
2001 10
2002 7
2003 6
2004 4
2005 7
2006 5
2007 1
2008 1
2009 3
2010 1
2011 1
2013 1
2014 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Insurance for independent cancer trials.
Perrone F, Marangolo M, Di Costanzo F, Colucci G, Repetto L, Merlano M, De Placido S, Torri V, Comella G, Labianca R, Parisi V, Gallo C. Perrone F, et al. Among authors: comella g. Ann Oncol. 2004 Nov;15(11):1722-3. doi: 10.1093/annonc/mdh444. Ann Oncol. 2004. PMID: 15520080 Free article. No abstract available.
Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.
Palmeri S, Vaglica M, Spada S, Filippelli G, Farris A, Palmeri L, Massidda B, Misino A, Ferraù F, Comella G, Leonardi V, Condemi G, Mangiameli A, De Cataldis G, Macaluso MC, Cajozzo M, Iannitto E, Danova M. Palmeri S, et al. Among authors: comella g. Oncology. 2005;68(4-6):438-45. doi: 10.1159/000086986. Epub 2005 Jul 14. Oncology. 2005. PMID: 16020974 Free article. Review.
Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study.
Frasci G, Comella P, D'Aiuto G, Budillon A, Barbarulo D, Thomas R, Capasso I, Casaretti R, Daponte A, Caponigro F, Gravina A, Maiorino L, Caratení G, Gentile A, Comella G. Frasci G, et al. Among authors: comella g. Breast Cancer Res Treat. 1998 May;49(1):13-26. doi: 10.1023/a:1005945218155. Breast Cancer Res Treat. 1998. PMID: 9694607 Clinical Trial.
Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study.
Frasci G, D'Aiuto G, Comella P, Thomas R, Capasso I, Di Bonito M, Rivellini F, Carteni G, De Lucia L, Maiorino L, D'Aniello R, Frezza P, Lapenta L, Comella G. Frasci G, et al. Among authors: comella g. Breast Cancer Res Treat. 2000 Jul;62(2):87-97. doi: 10.1023/a:1006429205363. Breast Cancer Res Treat. 2000. PMID: 11016746 Clinical Trial.
Temozolomide and cisplatin in avdanced malignant melanoma.
Daponte A, Ascierto PA, Gravina A, Melucci M, Scala S, Ottaiano A, Simeone E, Palmieris G, Comella G. Daponte A, et al. Among authors: comella g. Anticancer Res. 2005 Mar-Apr;25(2B):1441-7. Anticancer Res. 2005. PMID: 15865103 Free article. Clinical Trial.
110 results